Login

Forte Biosciences, Inc. SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G/A
04 Nov 2026 SCHEDULE 13G/A
08 Sep 2026 15-12G
08 Sep 2026 15-12G
08 Sep 2026 15-12G
08 Sep 2026 SCHEDULE 13G/A
01 Sep 2026 EFFECT
01 Sep 2026 EFFECT
01 Sep 2026 EFFECT
01 Sep 2026 EFFECT
01 Sep 2026 EFFECT
01 Sep 2026 EFFECT
27 Aug 2026 Form 4: Gryska David W, Director

Disposed of 5,940 shares (Tender Offer) · Disposed of 34,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 2,000 Stock Option (right to buy)] (Disposition to Issuer) · 1 more

27 Aug 2026 POS AM
27 Aug 2026 POS AM
27 Aug 2026 POS AM
27 Aug 2026 POS AM
27 Aug 2026 POS AM

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support